Digital Health: Page 2
-
Apple to sell watches without pulse oximetry after ban of original design takes effect
A court Wednesday denied Apple’s request for an extended stay on an import ban of its smartwatches, after the International Trade Commission found the products infringed Masimo’s patents.
By Susan Kelly • Jan. 18, 2024 -
Dermasensor wins FDA clearance for AI-enabled skin cancer detection device
A study found the sensitivity of the device was 96%, compared with 83% for primary care physicians.
By Nick Paul Taylor • Updated Jan. 22, 2024 -
Trendline
Medical device industry continues to turn to AI
While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.
By MedTech Dive staff -
EssilorLuxottica integrates tech into glasses to target hearing loss market
The glasses feature microphones, speakers and algorithms to amplify speech, but the technology is hidden in the frame.
By Nick Paul Taylor • Jan. 16, 2024 -
Apple, locked in patent fight with Masimo, redesigns smartwatch
The tech giant could bring to market watches without a pulse oximetry feature to avoid an ITC ban on sales of versions now on the market.
By Susan Kelly • Jan. 16, 2024 -
Masimo’s preliminary Q4 results, 2024 outlook exceed analyst expectations
Analysts see the update as evidence Masimo may be rebounding after failing to meet their expectations earlier in the year.
By Nick Paul Taylor • Jan. 11, 2024 -
Q&A
‘Healthy pullback’: GSR Ventures’ Sunny Kumar on normalizing digital health funding, accelerating M&A in 2024
Sunny Kumar discusses digital healthcare investment, the landscape for M&A and when the public markets could open back up.
By Emily Olsen • Jan. 8, 2024 -
Sponsored by Nuance
The power of generative AI in healthcare: Unmasking 5 key factors beyond the hype
With hundreds of startups emerging in the healthcare AI market, here are the five factors every clinical and business leader should consider when assessing a generative AI solution and vendor.
By Rebecca Schechter | Senior Vice President & General Manager, Dragon Ambient eXperience (DAX) • Jan. 8, 2024 -
Nanowear gets FDA clearance for undergarment that estimates blood pressure
The company’s continuous blood pressure monitor allows clinical investigators to remotely capture data on patients.
By Nick Paul Taylor • Jan. 5, 2024 -
Apple Watch sales resume after latest twist in Masimo patent case
An appeals court has granted Apple’s emergency motion to pause the U.S. International Trade Commission’s ban on sales of its watches with a pulse oximetry feature.
By Susan Kelly • Jan. 3, 2024 -
Apple to pause US sales of smartwatches with pulse oximetry
The tech giant’s move follows a USITC ruling that found the watches infringed some of Masimo's patents for measuring blood oxygen.
By Susan Kelly • Dec. 20, 2023 -
Tandem completes US launch of revamped diabetes management platform
The platform, Tandem Source, combines the features of the company’s legacy t:connect offerings with new data reports.
By Nick Paul Taylor • Dec. 15, 2023 -
Medtronic expands AI endoscopy partnership with Cosmo
The collaboration will focus on Cosmo Intelligent Medical Devices’ GI Genius module, which Medtronic distributes globally.
By Elise Reuter • Dec. 11, 2023 -
Dexcom, Hologic picked to outperform in 2024: William Blair
For the medtech industry overall, the analysts wrote that procedure volume growth is likely to normalize after declining due to the COVID-19 pandemic.
By Nick Paul Taylor • Dec. 7, 2023 -
Intuitive’s venture capital arm launches second investment fund
The $150 million fund will back early-stage companies focused on healthcare access, digital health, and precision diagnostics and interventions.
By Susan Kelly • Dec. 5, 2023 -
Resmed’s new C-suite focused on growing sleep apnea device demand: analysts
After gaining market share during the Philips recall, Resmed can keep growing by stimulating demand through marketing initiatives and new products, William Blair analysts wrote.
By Nick Paul Taylor • Dec. 4, 2023 -
Empatica aims to develop seizure-forecasting algorithm based on wearable data
The company plans a study using its wrist-worn device to capture real-world data that could help understand and predict seizures for people with epilepsy.
By Nick Paul Taylor • Dec. 1, 2023 -
GE HealthCare, Hologic put AI at center of radiology pitches
BTIG analysts said GE HealthCare believes AI can help clinicians and radiologists do their jobs better, which is important due to the “ongoing shortage of radiologists and the high rates of burn out.”
By Nick Paul Taylor • Dec. 1, 2023 -
Cleveland Clinic, Canon to establish medical imaging research center
Joint research projects will focus on pre-clinical imaging, human imaging and image analysis in cardiology, neurology and musculoskeletal medicine.
By Susanna Vogel • Nov. 30, 2023 -
GE HealthCare gets 510(k) clearance for algorithm to detect collapsed lungs
The system provides immediate notifications to support the triaging of emergency room patients.
By Nick Paul Taylor • Nov. 29, 2023 -
AstraZeneca creates digital health unit, with big-name partnerships already in place
Called Evinova, the unit will operate as a separate business within AstraZeneca, which sees digital health solutions as a market primed for growth.
By Jacob Bell • Nov. 20, 2023 -
Resmed overhauls C-suite, creating 3 posts and parting ways with 2 execs
The company recently laid off 5% of its staff and stopped certain projects to lower operating costs.
By Nick Paul Taylor • Nov. 13, 2023 -
Masimo lowers outlook, citing constrained hospital budgets
The patient monitoring company is also facing a slowdown in demand for the consumer audio products it acquired in a deal last year.
By Susan Kelly • Nov. 8, 2023 -
White House orders HHS to start collecting reports on the safety of AI in healthcare
President Joe Biden outlined the planned program as part of an executive order on “safe, secure, and trustworthy” artificial intelligence.
By Nick Paul Taylor • Nov. 1, 2023 -
Resmed cuts 5% of staff amid profitability push
The company has stopped some projects that were not working well as it seeks to cut operating costs, CEO Mick Farrell told investors.
By Elise Reuter • Oct. 30, 2023 -
Fresenius to develop AI models for dialysis care with new database of over 540,000 patients
The company said the project is “the largest multinational, longitudinal database of its kind.”
By Nick Paul Taylor • Oct. 30, 2023